Thoracic Specimen Registry
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMayo Clinic
About this trial
The purpose of the registry will be to support ongoing research in the etiology, early diagnosis, clinical management, and prognosis of lung cancer and other cancers and diseases of the thorax by developing a complete repository of specimens from patients with thoracic disease including but not limited to suspected lung cancer, mediastinal and pleural tumors, lung transplants and from patients at a very high risk of developing other thoracic cancers or other thoracic diseases.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Subject must be > 18 years of age
Presumed or known or screening of Thoracic Diseases (which includes but not limited to the following: thoracic neoplasms (masses/nodules) malignant or benign, interstitial lung diseases (ILD), chronic obstructive pulmonary disease (COPD), thoracic infections, thoracic malignancies metastatic to other organs, other cancers metastatic to the thoracic cavity.
Disqualifiers
None
Trial population
Mayo Clinic Rochester patients with thoracic disease
Trial design
Design model
Case-only
Time perspective
Prospective
Treatments tested in this trial
Tissue Banking
Other interventionBlood, tissue, and fluid collection
Treatment groups
7,000 Participants
are divided into 1 treatment groupGroup A: Thoracic Disease1 intervention
Trial outcomes
Primary outcomes
1
Thoracic Specimen Repository
Number of thoracic specimens collected
Time frame
Through study completion, approximately 10 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov